Daily Technical Analysis Weekly Analysis Monthly Analysis Renko chart MACD chart Bollinger Bands chart Stochastics charts Force Index charts

(GLAXO) Glaxosmithkline Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Glaxosmithkline Pharmaceuticals | (GLAXO) share price targets

Complete technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) by charts plus indicators, forecast predictions and share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Glaxosmithkline Pharmaceuticals trades in NSE in Pharmaceuticals sector.

Showing technical analysis as on 2025-01-27 View latest technical analysis

10 day averaged volume of Glaxosmithkline Pharmaceuticals is 134133

Date	Daily Closing Price	Open	High	Low	Volume
27 Mon Jan 2025	2062.30	2094.15	2094.15	2031.50	1.607 times
24 Fri Jan 2025	2099.55	2104.50	2113.30	2039.05	1.058 times
23 Thu Jan 2025	2087.60	2105.00	2141.45	2080.00	1.799 times
22 Wed Jan 2025	2107.85	2151.35	2164.85	2089.40	1.884 times
21 Tue Jan 2025	2146.00	2128.30	2202.00	2110.10	1.248 times
20 Mon Jan 2025	2135.50	2065.00	2149.50	2048.00	0.834 times
17 Fri Jan 2025	2063.30	2050.00	2069.70	2013.85	0.768 times
16 Thu Jan 2025	2053.05	2052.00	2069.20	2013.30	0.45 times
15 Wed Jan 2025	2042.50	2086.00	2116.40	1987.00	0.847 times
14 Tue Jan 2025	2072.05	2100.05	2118.00	2051.00	0.494 times

My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 2076.1, but if it comes above 2076.1, then a intra day buy could be more profitable.
If you take a sell trade below 2076.1, then use 2076.1 as stoploss and 1990.5 as target. However if you take a buy trade in stock , then use 2076.1 as stoploss and 2147.34 as target.

Share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Target	1987.00
Downside Target	2031.50
Upside Target	2094.15
Upside Target	2141.35
Upside Target	2248.95
Upside Target	2307.00
Upside Target	2457.75
Upside Target	2500.00
Upside Target	2676.25
Upside Target	2742.95
Upside Target	2889.90
Upside Target	2922.80

Intraday share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Intraday Target	2031.15
Downside Intraday Target	2000
Upside Intraday Target	2093.8
Upside Intraday Target	2125.3
Upside Intraday Target	2062.65

Weekly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Weekly Closing Price	Open	High	Low	Volume
27 Mon Jan 2025	2062.30	2094.15	2094.15	2031.50	0.235 times
24 Fri Jan 2025	2099.55	2065.00	2202.00	2039.05	2.148 times
17 Fri Jan 2025	2063.30	2143.00	2165.80	1987.00	1.227 times
10 Fri Jan 2025	2190.40	2236.00	2248.95	2141.35	0.751 times
03 Fri Jan 2025	2241.05	2274.45	2280.15	2158.40	3.053 times

Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.

Monthly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Monthly Closing Price	Open	High	Low	Volume
27 Mon Jan 2025	2062.30	2235.00	2272.00	1987.00	1.153 times
31 Tue Dec 2024	2251.85	2436.00	2457.75	2158.40	0.973 times
29 Fri Nov 2024	2444.40	2729.00	2742.95	2307.00	0.867 times
31 Thu Oct 2024	2712.25	2751.00	2889.90	2500.00	1.386 times

Scroll below to view daily charts

Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.

Indicators analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Glaxosmithkline Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a BUY signal for Glaxosmithkline Pharmaceuticals in short term but the buy signal is initial and weak.

Glaxosmithkline Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Glaxosmithkline Pharmaceuticals in short term and SELL signal is strong!

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Glaxosmithkline Pharmaceuticals is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2091.51 and Glaxosmithkline Pharmaceuticals (GLAXO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Glaxosmithkline Pharmaceuticals (GLAXO) stock. Volume based technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) stock is negative.

Glaxosmithkline Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.